Related content

How to use myocardial 123 I-MIBG scintigraphy in chronic heart failure

By Agostini Denis  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 36, Iss. 4, 2009-04 ,pp. : 555-559

Springer Publishing Company

Access to resources Recommend Favorite

Significance of I-123 metaiodobenzylguanidine (¹²³I-MIBG) lung activity in subjects with heart failure in comparison to healthy control subjects

By Gerson Myron   Dwivedi Alok   Abdallah Mouhamad   Shukla Rakesh   Jacobson Arnold  

Journal of Nuclear Cardiology, Vol. 20, Iss. 4, 2013-08 ,pp. : 592-599

Springer Publishing Company

Access to resources Recommend Favorite

Variations in ¹²³I-metaiodobenzylguanidine (MIBG) late heart mediastinal ratios in chronic heart failure: a need for standardisation and validation

By Verberne Hein   Habraken Jan   Eck-Smit Berthe   Agostini Denis   Jacobson Arnold  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 35, Iss. 3, 2008-03 ,pp. : 547-553

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic values of initial responses to low-dose ¹³¹I-MIBG therapy in patients with malignant pheochromocytoma and paraganglioma

By Wakabayashi Hiroshi   Taki Junichi   Inaki Anri   Nakamura Ayane   Kayano Daiki   Fukuoka Makoto   Matsuo Shinro   Nakajima Kenichi   Kinuya Seigo  

Annals of Nuclear Medicine, Vol. 27, Iss. 9, 2013-11 ,pp. : 839-846

Springer Publishing Company

Access to resources Recommend Favorite

EANM procedure guidelines for ¹³¹I-meta-iodobenzylguanidine (¹³¹I-mIBG) therapy

By Giammarile Francesco   Chiti Arturo   Lassmann Michael   Brans Boudewijn   Flux Glenn  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 35, Iss. 5, 2008-05 ,pp. : 1039-1047

Springer Publishing Company

Access to resources Recommend Favorite